Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
返回列表
CONTACT: Investors/Media, Blaine Davis, +1-610-459-7158, Media, Kevin Wiggins, +1-610-459-7281, or Investors, Jonathan Neely, +1-610-459-6645
Web Site: http://www.endo.com
Posted: June 2011